The Center on Drug Policy Evaluation outlines drug policy reform and harm reduction priorities they believe the Biden administration should immediately act upon.
FEDITO BLX and IDPC make recommendations for Belgium's UPR, focusing on adopting a public health approach, decriminalising people who use drugs and providing a clear legal framework for drug consumption rooms.
INPUD interrogates 'progress' toward decriminalisation, pointing to gaps and pending challenges, including in relation to enduring stigmatisation and prohibition.
IDPC provides a critique of the UNODC Strategy 2021-2025 with a focus on two critical issues: the exclusion of civil society and communities from the development and approval of the document; and the departure from the policy priorities established in the 2018 UN system Common Position on drugs.
IDPC takes stock of progress made on the implementation of the recommendations included in the UNGASS Outcome Document, focusing on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation.
